In English
NIDA

Adicción al tabaco

Referencias

  1. Adams, E.K.; Miller, V.P.; Ernst, C.; Nishimura, B.K.; Melvin, C.; y Merritt, R. Neonatal health care costs related to smoking during pregnancy. Health Economics 11:193–206, 2002.
  2. Belluzzi, J.D.; Wang, R.; y Leslie, F.M. Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacol 30:705–712, 2005.
  3. Benowitz, N.L. Pharmacology of nicotine: Addiction and therapeutics. Ann Rev Pharmacol Toxicol 36:597–613, 1996.
  4. Breslau, N., y Johnson, E.O. Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health 90(7):1122–1127, 2000.
  5. Buka, S.L.; Shenassa, E.D.; y Niaura, R. Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: A 30-year prospective study. Am J Psychiatry 160:1978–1984, 2003.
  6. Covey, L.S.; Glassman, A.H.; y Stetner, F. Major depression following smoking cessation. Am J Psychiatry 154:263–265, 1997.
  7. Dervaux, A., y Laqueille, X. Smoking and schizophrenia: Epidemiological and clinical features. Encephale 34(3):299–305, 2008.
  8. Ernst, M.; Moolchan, E.T.; y Robinson, M.L. Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 40:630–641, 2001.
  9. Fowler, J.S.; Volkow, N.D.; Wang, G.J.; Pappas, N.; Logan, J.; MacGregor, R.; Alexoff, D.; Shea, C.; Schlyer, D.; Wolf, A.P.; Warner, D.; Zezulkova, I.; y Cilento, R. Inhibition of monoamine oxidase B in the brains of smokers. Nature 22:733–736, 1996.
  10. Hatsukami, D.K.; Lemmonds, C.; Zhang, Y.; Murphy, S.E.; Le, C.; Carmella, S.G.; y Hecht, S.S. Evaluation of carcinogen exposure in people who used “reduced exposure” tobacco products. J Natl Cancer Inst 96:844–852, 2004.
  11. Henningfield, J.E. Nicotine medications for smoking cessation. New Engl J Med 333:1196–1203, 1995.
  12. Ilomäki, R., y cols. Temporal association of onset of daily smoking with adolescent substance use and psychiatric morbidity. Eur Psychiatry 23(2):85–91, 2008.
  13. John, U.; Meyer, C.; Rumpf, H.J.; y Hapke, U. Smoking, nicotine dependence and psychiatric comorbidity: A populationbased study including smoking cessation after three years. Drug Alcohol Depend 76:287–295, 2004.
  14. Johnston, L.D.; O’Malley, P.M.; Bachman, J.G.; y Schulenberg, J.E. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2008. NIH Pub. No. 09-7401. Bethesda, MD: National Institute on Drug Abuse, 2009. Disponible en: www.monitoringthefuture.org.
  15. Kalman, D.; Morissette, S.B.; y George, T.P. Comorbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 14(2):106–123, 2005.
  16. Kollins, S.H.; McClernon, F.J.; y Fuemmeler, B.F. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a populationbased sample of young adults. Arch Gen Psychiatry 62:1142–1147, 2005.
  17. Levin, E.D.; Rezvani, A.H.; Montoya, D.; Rose, J.E.; y Swartzwelder, H.S. Adolescent-onset nicotine self–administration modeled in female rats. Psychopharmacol 169:141–149, 2003.
  18. Morissette, S.B.; Tull, M.T.; Gulliver, S.B.; Kamholz, B.W.; y Zimering, R.T. Anxiety, anxiety disorders, tobacco use, and nicotine: A critical review of interrelationships. Psychol Bull 133(2):245–272, 2007.
  19. Perkins, K.A.; Donny, E.; y Caggiula, A.R. Sex differences in nicotine effects and self–administration: Review of human and animal evidence. Nic and Tobacco Res 1:301–315, 1999.
  20. Saccone, S.F., y cols. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16(1):36–49, 2007.
  21. Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on Drug Use and Health: National Findings. DHHS Pub. No. SMA 09-4434. Rockville, MD: Office of Applied Studies, 2009. Disponible en: http://oas.samhsa.gov/nsduh/2k8nsduh/2k8Results.cfm.
  22. Thorgeirsson, T.E., y cols. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452(7187):638–642, 2008.
  23. U.S. Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2000. Disponible en: http://www.cdc.gov/tobacco/data_statistics/sgr/index.htm.
  24. U.S. Department of Health and Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990. Disponible en: http://www.cdc.gov/tobacco/data_statistics/sgr/index.htm.
  25. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004. Disponible en: http://www.cdc.gov/tobacco/data_statistics/sgr/2004/index.htm.
  26. Upadhyaya, H.P.; Deas, D.; Brady, K.T.; y Kruesi, M. Cigarette smoking and psychiatric comorbidity in children and adolescents. J Am Acad Child Adolesc Psychiatry 41(11):1294–1305, 2002.

Página actualizada en Marzo del 2010

Serie de reportes de investigación

Esta serie de reportes, dirigida al público en general, los legisladores, los grupos educativos y los profesionales de la salud, explica la ciencia detrás de los resultados de la investigación.  La serie informa sobre los resultados de las investigaciones de interés nacional.

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas